AzTrials
AzTrials

Alcohol Use DisorderNCT03816527

Selective Attention in Alcohol Use Disorder

An observational study of Alcohol Use Disorder, run by Central Institute of Mental Health, Mannheim at 1 site in Germany.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study examines the selective attention to emotional- and alcohol- associated cues in alcohol- dependant and healthy participants. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Alcohol Use Disorder
How many people
0 participants
Where
1 siteGermany
Study dates
1 Jan 2019to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: group 1: patients with alcohol use disorder, recruited in the Clinic of the Department of Addictive Behaviour and Addiction Medicine group 2: healthy controls, recruited from the local community

Who may be able to join

  • Women of childbearing age
  • Women an Men between 18 and 65 years
  • Adequate ability to reach an Agreement with the Investigator, to answer oral and written questions
  • Ability to consent after detailed reconnaissance
  • Written informed consent
  • Patients: Diagnosis of alcohol use disorder

Who cannot join

  • Participants wich are unable to consent
  • Severe internal, neurological ans psychiatric comorbidities
  • Abstinence phenomenon (CIWA-R > 3)
  • Axis I psychiatric disorder (except nicotine dependence and specific phobias within the last 12 months as well as patients with alcohol use disorder)
  • Pharmacotherapy with psychoactive substances

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit

    Mannheim

Other trials in Germany

About this study

Official title: Selective Attention to Emotional and Alcohol-associated Cues in Patients With Alcohol Use Disorder and Healthy Participants

This study examines the selective attention to emotional- and alcohol- associated cues in alcohol- dependant and healthy participants.

Read the detailed description

The planned study will investigate the selective attention to emotional and alcohol-related stimuli in alcohol-dependent patients and healthy volunteers.

background Attitudinal shifts in the implicit cognitive processing of alcohol-associated stimuli play a major role in the maintenance of addictive disorders, in the development of alcohol cravings, and ultimately in relapse. There are several experimental methods to study the selective attention to image stimuli. For preliminary studies as well as for the planned study, we opted for the so-called Dotprobe task , in which image pairs (alcohol versus neutral stimulus) are presented. The selective attention can be measured by means of reaction time differences. In addition to alcohol-related stimuli, photos of fearful and happy faces that act as emotional stimuli are also used.

In a preliminary study, the investigators were able to show that not only alcoholics, but also healthy light social drinkers, showed an initial orientation towards alcohol stimuli. The presence of such a shift in attention to alcoholic stimuli, even in healthy individuals, could be a consequence of the processing of alcoholic stimuli as emotional stimuli of increased salience compared to affectively neutral stimuli. There are still no studies that collectively examine selective attention to both emotional and alcohol-associated stimuli. While some studies have shown selective attention to fear stimuli compared to neutral stimuli only in populations with clinically relevant increased anxiety, there are also studies who were able to show that there is selective attention to evolutionarily relevant anxiety even in healthy individuals. In these non-clinical populations, this selective attention appears to be particularly prevalent in subjects with increased anxiety.

Studies using affective positive stimuli such as happy faces showed selective attention to these positive valent stimuli in healthy people compared to neutral stimuli, which was also associated with the current mood . Thus, the selective attention to cheerful faces, for example, in a positive mood was also increased. Emotional processing is relevant in the development and maintenance of addictive diseases as well as in so-called "prolonged withdrawal". Thus, during abstinence among alcoholics, increased anxiety, irritability and dysphoria, the so-called "negative emotional state of withdrawal", appear. In a functional Magnetic Resonance Imaging (fMRI) study, it was shown that when anxious faces were seen, acute alcohol abuse had anxiolytic effects. In a separate study with disgusting images on cigarette packs as an aversive fear stimuli, we found that smokers showed a shift in attention to these disgusting images was associated with relief craving and was also associated with increased anxiety, especially in heavy smokers.

Objective:

The study will compare the selective attention to emotional and alcohol-related stimuli between alcoholics and healthy people. Furthermore, their association with positive and negative mood as well as anxiety should be considered. The aim is to investigate whether alcoholic stimuli are processed the same way in healthy people, such as appetitive, emotional stimuli and whether patients' alcohol stimuli are processed like aversive, emotional stimuli.

This question is interesting both methodically and clinically. On the one hand, it would be methodologically important to interpret whether healthy alcohol-associated stimuli are appetitive or similar to affectively positive stimuli for the interpretation of studies on selective attention to alcohol stimuli and alcohol-stimulant reactivity. Clinically significant would be the identification of patients with increased selective attention to alcohol and anxiety stimuli, for whom the risk of relapse could be increased by confronting these stimuli. From these findings, therapeutic options could be derived, such as the application of exposure therapies.

Hypotheses:

  1. Alcohol-dependent patients as well as healthy volunteers have a selective shift of attention to alcohol-associated versus neutral stimuli.
  2. The selective attention to happy faces is associated with positive mood.
  3. The selective attention to anxious faces is associated with the degree of anxiety.
  4. The selective attention to anxious faces is increased in alcoholics compared to healthy controls.
  5. The selective attention to happy faces is lowered in alcoholics in comparison to healthy controls.
  6. Selective attention to alcohol-associated stimuli in healthy controls is associated with positive mood.
  7. Selective attention to alcohol-related stimuli is associated with negative mood in alcohol-dependent patients.

Target population:

The study will examine 40 alcohol-dependent patients and 40 healthy volunteers.

Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03816527
Study groupRoleWhat they receive
AUD patientsIndividuals with alcohol use disorder
Healthy controlsHealthy controls

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. attentional bias to alcohol cues

    measured with reaction time differences (in milliseconds) using the dotprobe-task (Vollstädt-Klein et al. 2009) [reaction time differences is not a change over time; it is measured during one experimental session]

    Measured: at examination 1 day (single examination, no follow-up)

  2. attentional bias to emotional cues

    measured with reaction time differences (in milliseconds) using the dotprobe-task (like in Vollstädt-Klein et al. 2009, but with emotional pictures) [reaction time differences is not a change over time; it is measured during one experimental session]

    Measured: at examination 1 day (single examination, no follow-up)

Secondary outcomes (6)
  1. severity of nicotine dependence

    Fagerstrøm Test of Nicotine Dependence (Heatherton, Kozlowski, Frecker, \& Fagerstrom, 1991)

    Measured: at examination 1 day (single examination, no follow-up)

  2. nicotine consumption

    amount of nicotine consumed during the last 3 months (like (Scheurich et al., 2005) but for nicotine instead of alcohol)

    Measured: at examination 1 day (single examination, no follow-up), retrospectively for the last 3 months

  3. alcohol consumption

    amount of alcohol consumed during the last 3 months (Scheurich et al., 2005)

    Measured: at examination 1 day (single examination, no follow-up), retrospectively for the last 3 months

  4. severity of alcohol use disorder

    Alcohol Dependence Scale, ADS (Skinner \& Horn, 1984), score ranges between 0 and 47, higher score means higher severity of alcohol use disorder

    Measured: at examination 1 day (single examination, no follow-up),

  5. habitual alcohol consumption

    automated and habitual alcohol consumption during the last 7 days, measured with Craving Automated Scale for Alcohol" (CAS-A) (Vollstädt-Klein et al., 2015). 5 subscales (factors): Factor 1 ("only aware in hindsight") ranges from 0 to 35, factor 2 ("no deliberate decision") from 0 to 35, factor 3 ("contrary to intention") from 0 to 40, factor 4 ("no perception") from 0 to 20, and factor 5 ("no control") from 0 to 10. , higher score means more habitual alcohol consumption

    Measured: at examination 1 day (single examination, no follow-up), retrospectively for the last 7 days

  6. alcohol craving

    measured with Obsessive Compulsive Drinking Scale (OCDS, (Mann \& Ackermann, 2000)), score ranges between 0 and 40, higher score means higher craving (obsessive-compulsive alcohol use)

    Measured: at examination 1 day (single examination, no follow-up), retrospectively for the last 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2019
  2. Study start1 Jan 2019
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Why it stopped: study not funded / no manpower

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03816527
Sponsor's protocol ID
Emo-Dotprobe
Status last verified
Apr 2025
First submitted
7 Jan 2019
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Alcohol Use Disorder, run by Central Institute of Mental Health, Mannheim at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

attentional bias to alcohol cues (time frame: at examination 1 day (single examination, no follow-up)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in